The COVID-19 pandemic is a global emergency. Identifying populations who are at risk of severe complications is crucial in developing special measures to prevent or reduce severe illness and mortality in vulnerable patients. Emerging evidence indicates that alpha1-proteinase inhibitor might inhibit infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). α1-AntitrypsinContinue Reading

18th October 2020  Professor Gerry McElvaney (left), the study’s senior author and a consultant in Beaumont Hospital, and Professor Ger Curley (right) stand in front of the RCSI Education and Research Centre in Beaumont Hospital, Dublin.   Scientists have developed, for the first time, a score that can accurately predictContinue Reading

  RESEARCH TRIANGLE PARK — Grifols, a global biotherapeutics company, has begun Phase 3 clinical trials in patients with COVID-19 with its therapeutic manufactured in Clayton. The Spanish company is testing its hyperimmune globulin for its safety, effectiveness and tolerability as a weapon to combat SARS-CoV-2, the virus that causes COVID-19. SinceContinue Reading

RICHLAND, WA- The Wishing Star Foundation is a non-profit based out of Spokane that grants the wishes of children ages 3-21 with terminal, life threatening or medically complicated conditions. Friday the non-profit granted the wish of a young Richland girl named Oaklee McBride. Oaklee has Alpha-1 Antitrypsin Deficiency an inherited condition thatContinue Reading

[Warning: The below contains MAJOR spoilers for Season 16, Episode 15 of Grey’s Anatomy, “Snowblind.”] The blizzard isn’t the only disaster in this Grey’s Anatomy episode—Season 16, Episode 15 Hayes’ patient this week is Elisa, a 6-year-old with alpha-1 antitrypsin deficiency—the same disorder that killed her older sister, one of Alex’s patients. ElisaContinue Reading